Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
|
Buy Now
Precision Medicine in Neurodegenerative Disorders, Volume 192 - Part I (Hardcover)
Loot Price: R5,361
Discovery Miles 53 610
|
|
Precision Medicine in Neurodegenerative Disorders, Volume 192 - Part I (Hardcover)
Series: Handbook of Clinical Neurology
Expected to ship within 12 - 17 working days
|
Precision Medicine in Neurodegenerative Disorders, Part One, Volume
192 deals with the "Why" in the approach to slow the progression of
those suffering from diseases of accelerated brain aging. Matching
a biology-correcting therapy with those biologically suitable to
benefit from such therapy represents the vision and mission of
precision medicine, the highest level of personalized medicine.
This first Handbook of Clinical Neurology volume is intended to
provide a scholarly background on the framework, basic science, and
conceptual pitfalls related to disease-modifying efforts in
Parkinson, Alzheimer, and other neurodegenerative disorders. Among
the topics covered are the different models of precision medicine,
the lumping-versus-splitting tension in biomarker development and
therapeutics, and the rationale for replacing the convergence of
the prevailing autopsy-based nosology of neurodegenerative diseases
with the divergence of a systems biology approach to human
diseases. Specific chapters are dedicated to the promise of genetic
subtypes and the lessons in disease modification offered by the
fields of oncology and cystic fibrosis that can be adapted to the
field of neurodegeneration.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.